The original rise of Sildenafil presented a massive prospect for the market, but its period has ended, creating a intricate landscape. Alternative versions have appeared in the arena, diminishing sales and putting a strain on profit percentages . While established healthcare companies maintain a foothold in this area, the future remains unclear by